Extract from the Register of European Patents

EP About this file: EP2496948

EP2496948 - COMPOSITIONS AND METHODS FOR DETECTING PLECTIN-1 AS A BIOMARKER FOR CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2018
Database last updated on 18.03.2026
FormerThe patent has been granted
Status updated on  08.12.2017
FormerGrant of patent is intended
Status updated on  05.07.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK
published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
University of Virginia Patent Foundation
722 Preston Ave., Suite 107
Charlottesville VA 22903 / US
[2017/35]
Former [2012/37]For all designated states
University Of Virginia Patent Foundation
250 West Main Street Suite 300
Charlottesville, VA 22902 / US
Inventor(s)01 / KELLY, Kimberly A.
1076 Autumn Hill Court
Crozet, Virginia 22932 / US
 [2012/37]
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2018/02]Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2013/45]Fyfe, Fiona Allison Watson, et al
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2012/37]Ouzman, Beverley Nicola Claire
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date10829151.905.11.2010
[2018/02]
WO2010US55632
Priority number, dateUS20090258242P05.11.2009         Original published format: US 258242 P
[2012/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011057078
Date:12.05.2011
Language:EN
[2011/19]
Type: A2 Application without search report 
No.:EP2496948
Date:12.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 12.05.2011 takes the place of the publication of the European patent application.
[2012/37]
Type: B1 Patent specification 
No.:EP2496948
Date:10.01.2018
Language:EN
[2018/02]
Search report(s)International search report - published on:KR22.09.2011
(Supplementary) European search report - dispatched on:EP07.04.2014
ClassificationIPC:G01N33/68, G01N33/58, G01N33/574
[2012/37]
CPC:
A61K51/088 (EP,US); G01N33/68 (KR); A61K47/64 (EP,US);
A61K49/0002 (EP,US); A61K51/0482 (US); A61K51/065 (US);
A61P35/00 (EP); A61P35/04 (EP); C07K14/00 (US);
C07K7/06 (EP,US); G01N33/52 (KR); G01N33/531 (EP,US);
G01N33/575 (EP,US); G01N33/60 (KR); G01N2333/4724 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/37]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ERKENNUNG VON PLECTIN-1 ALS BIOMARKER FÜR KREBS[2012/37]
English:COMPOSITIONS AND METHODS FOR DETECTING PLECTIN-1 AS A BIOMARKER FOR CANCER[2012/37]
French:COMPOSITIONS ET PROCÉDÉS DE DÉTECTION LA PLECTINE-1 COMME BIOMARQUEUR POUR LE CANCER[2012/37]
Entry into regional phase15.05.2012National basic fee paid 
15.05.2012Search fee paid 
15.05.2012Designation fee(s) paid 
15.05.2012Examination fee paid 
Examination procedure15.05.2012Examination requested  [2012/37]
28.10.2014Amendment by applicant (claims and/or description)
22.10.2015Despatch of a communication from the examining division (Time limit: M04)
09.02.2016Reply to a communication from the examining division
01.07.2016Despatch of a communication from the examining division (Time limit: M04)
30.09.2016Reply to a communication from the examining division
06.07.2017Communication of intention to grant the patent
29.09.2017Fee for grant paid
29.09.2017Fee for publishing/printing paid
29.09.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.10.2015
Opposition(s)11.10.2018No opposition filed within time limit [2018/51]
Fees paidRenewal fee
25.01.2013Renewal fee patent year 03
27.11.2013Renewal fee patent year 04
26.11.2014Renewal fee patent year 05
30.11.2015Renewal fee patent year 06
28.11.2016Renewal fee patent year 07
27.11.2017Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.11.201203   M06   Fee paid on   25.01.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.11.2010
AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
MK10.01.2018
NL10.01.2018
PL10.01.2018
PT10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
[2020/31]
Former [2020/30]HU05.11.2010
AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
PT10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2020/27]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
PT10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2020/16]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
TR10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2019/33]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
MC10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2019/13]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SI10.01.2018
SK10.01.2018
SM10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/52]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SK10.01.2018
SM10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/51]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
DK10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SK10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/50]AL10.01.2018
AT10.01.2018
CY10.01.2018
CZ10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
SK10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/49]AL10.01.2018
AT10.01.2018
CY10.01.2018
EE10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RO10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/47]AL10.01.2018
AT10.01.2018
CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
IT10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/46]AL10.01.2018
AT10.01.2018
CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/40]AT10.01.2018
CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
BG10.04.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/39]AT10.01.2018
CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
LV10.01.2018
NL10.01.2018
PL10.01.2018
RS10.01.2018
SE10.01.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/38]AT10.01.2018
CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
PL10.01.2018
NO10.04.2018
GR11.04.2018
IS10.05.2018
Former [2018/37]CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
PL10.01.2018
NO10.04.2018
GR11.04.2018
Former [2018/36]CY10.01.2018
ES10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
PL10.01.2018
NO10.04.2018
Former [2018/35]CY10.01.2018
FI10.01.2018
HR10.01.2018
LT10.01.2018
NL10.01.2018
NO10.04.2018
Former [2018/34]FI10.01.2018
LT10.01.2018
NL10.01.2018
NO10.04.2018
Documents cited:Search[XDI] WO2009129220  (GERERAL HOSPITAL CORP et al.) [XD] 1,3,5,7,9-12,14,15 * the whole document *[I] 1,3-12,14,15
 [A] WO2009132020  (UNIV CALIFORNIA et al.) [A] 1-15 * the whole document *
 [A] US2008267882  (CHEN XIAOYUAN et al.) [A] 1-15 * the whole document *
International search[A]   KELLY K.A. ET AL: "Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma", PLOS MED., vol. 5, no. 4, E85, 15 April 2008 (2008-04-15), pages 657 - 668, XP008143633 [A]
 [A]   LEUNG KAM: "Lys-Thr-Leu-Leu-Pro-Thr-Pro-cross-linked iron oxide-Cy5.5 [PTP-CLIO-Cy5.5]", MOLECULAR IMAGING AND CONTRAST AGENT DATABASE(MICAD), 8 August 2008 (2008-08-08), XP008143627 [A]
 [A]   BAUSCH D. ET AL: "Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms", J GASTROINTEST SURG., vol. 13, no. 11, November 2009 (2009-11-01), pages 1948 - 1954, XP055093924 [A]

DOI:   http://dx.doi.org/10.1007/s11605-009-1001-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.